Celadon Pharmaceuticals Share Discussion Threads

[dpeach] 20/7/2009 08:19

anybody seen it tipped anywhere as many trying to get in first thing (usually occurs after a tip / or info.) Thought robbie burns may have tipped now back from greece but nothing posted on his website yet..so anyone else, shares mag, investors chronicle?

[dpeach] 20/7/2009 08:12

Flow, UPPPPPOLA I think were going north....

[go with the flow] 17/7/2009 10:27

As stated by others the price is kissing the support line of the up-channel formed last October.
Also nice breach of near term resistance @ circa 188p.
Next resistance @ 200p.
Uppola!
Flow

[boadicea] 16/7/2009 21:47

Agreed, chart does look encouraging.
A firm uptrend dates from October last year and rises at about 1.5p per week with a width of around 30p.
At the moment we are only a couple of pence above the lower side or from the time perspective a week or so in hand.
It therefore needs to keep rising or we should soon drop out of the channel.
The upper side would currently take us to ~218p . It would be nice to visit that sometime - prompted perhaps by the next tu?
Unfortunately a general dip in the market could easily thwart that hope although I anticipate that whatever the background situation CEL will exhibit relative strength.
A fair wind should at least see us through 200p by mid-September.

[dpeach] 16/7/2009 16:07

on both the LSE:Cel chart and the PLUS:CEL.GB chart seem to have very nice ascending coils, lovely

[dpeach] 16/7/2009 11:44

uppola, very solid stuff (as per this years results), can't find AGM date anywhere, anyone know off hand ??

[dpeach] 08/7/2009 13:33

Dennis someone is happy to invest divi or not 255,000 bought today, NAV?
Flow - the only way is uppola ;-)

[go with the flow] 08/7/2009 12:04

Uppola Peachy ;o)
Flow

[dpeach] 08/7/2009 08:14

slowly but surely... Dennis have you emailed Robyn or Jay, maybe another reason for not introducing the divi at this particular time.

[dennis russell] 06/7/2009 16:42

I think it was a mistake to drop the dividend, and another mistake not to re-introduce it after a sound set of results. It suggests the directors are not confident about the future, and it also prevents certain institutions from investing. Do you feel the same way? If so, tell them!

[dpeach] 06/7/2009 12:47

have i missed something, have we got an AGM date yet? (end july usually)

[dpeach] 06/7/2009 11:27

sorry boad ;-)... up on sells? background buying again by NAV?

[boadicea] 06/7/2009 10:23

Don't get excited. It's only had two small trades so far today and they were both 'sells' on Plus.

[go with the flow] 06/7/2009 10:11

A sustained breach of 190p would represent an optimistic chart.
Flow

[dpeach] 06/7/2009 09:57

whoosh... (and uppola)

[dpeach] 02/7/2009 11:57

up again, on a rubbish day for the merkat so far... keep it up

[dpeach] 01/7/2009 11:50

Flow - uppola I concur

[go with the flow] 01/7/2009 10:42

Hi Peachy!
I concur - uppola from here ;o)
Flow

[dpeach] 01/7/2009 09:22

now moving up nicely following the upward trend. IMHO as per robbie burns, positive results in very trying times, good cash control, so as global economic circumstances start to improve should be able to take a good advantage

[dpeach] 29/6/2009 08:21

From Naked Trader on 24th June




Brilliant set of results from Celsis - they are starting to move up and look undervalued to me after those figs

[dpeach] 28/6/2009 15:32

From Investors Chronicle :

Celsis pushes profits higher

Created: 26 June 2009 Written by: Jonas Crosland

Celsis International delivered a decent performance, thanks to another solid result from its Rapid Detection division which tests pharmaceutical company products for contamination. Turnover there rose 9.2 per cent to $23.7m (£14.5m).

However, turnover fell 13 per cent to $10.7m at IVT, Celsis' unit that supplies human and animal cells to drug developers for the purposes of carrying out early-stage safety tests on new drugs. Business levels declined following consolidation within the pharmaceutical industry and a general squeeze on research and development budgets as a result of the economic downturn.

Meanwhile, sales at the Analytical Services division, which provides outsourced laboratory testing services to pharmaceutical and consumer product companies, fell 4.7 per cent to $18.1m - although business picked up in the second half after falling 9.2 per cent in the first half. And following a strategic review, Celsis has decided to close the loss making Development Services division, which provided very early-stage and pre-clinical drug development laboratory services. Ongoing losses and closure related costs totalled $2.4m.

Celsis continues to run a tight ship, though, and reduced operating expenses by 9.7 per cent to $23.5m. Moreover, cash flow from continuing operations rose from $12.9m to $13.7m and, while the gross margin did edge slightly lower, it still stands at an impressive 69.8 per cent.

CELSIS INTERNATIONAL (CEL)
ORD PRICE: 182p MARKET VALUE: £39.8m
TOUCH: 179-186p 12-MONTH HIGH: 200p LOW: 129p
DIVIDEND YIELD: nil PE RATIO: 7
NET ASSET VALUE: 251c* NET CASH: $4.6m


Year to 31 Mar Turnover ($m) Pre-tax profit ($m) Earnings per share (¢) Dividend per share (¢)
2005 30.4 6.20 35.7 5.10
2006 33.1 7.20 20.8 nil
2007 47.4 8.70 26.8 nil
2008 52.9 10.5 32.8 nil
2009 52.5 12.8 41.9 nil
% change -1 +22 +28 -
Ex-div: -

Payment: -

*Includes intangible assets of $32.3m, or 147¢ a share £1 = $1.631



Click here for a guide to the terms used in IC results tables

For more analysis of company results as they're released, go to www.investorschronicle.co.uk/results


--------------------------------------------------------------------------------

IC VIEW:
GoodValueCelsis has cut costs and improved cash flow, while demand for its rapid detection services remains robust. True, there has been a slowdown in companies spending on research, but Celsis is well placed to take advantage of any improvement. Good value.

Last IC view: Buy, 144p, 17 November 2008.

[go with the flow] 25/6/2009 10:50

Fundamentally sound & from the technical chart perspective still positive.
So I guess the concensus is OK.
Flow

[verger] 25/6/2009 09:28

Balance of opinion moving to the positive; now we need the bid to rise closer to the offer price.

[verger] 24/6/2009 08:35

Yes, positives and negatives...as you would expect in present climate. I think results show the good quality of management in difficult times. Well done Cel.